Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Slim Fourati

Showing results (171-180 of 185) with videos related to

Pageof 19
Sort By:
The Journal of Clinical Investigation|May 1, 2024
Integrated longitudinal multiomics study identifies immune programs associated with acute COVID-19 severity and mortalityJeremy P Gygi, Cole Maguire, Ravi K Patel, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 30, 2021
Performance of 30 commercial SARS-CoV-2 serology assays in testing symptomatic COVID-19 patientsChristelle Vauloup-Fellous, Sarah Maylin, Claire Périllaud-Dubois, et al.
Annals of Intensive Care|April 24, 2024
COVID-19 associated pulmonary aspergillosis in critically-ill patients: a prospective multicenter study in the era of Delta and Omicron variantsPierre Bay, Etienne Audureau, Sébastien Préau, et al.
Biorxiv : the Preprint Server for Biology|November 21, 2023
Integrated longitudinal multi-omics study identifies immune programs associated with COVID-19 severity and mortality in 1152 hospitalized participantsJeremy P Gygi, Cole Maguire, Ravi K Patel, et al.
The Lancet. Microbe|June 2, 2026
Real-world emergence of nirsevimab resistance in breakthrough infections with respiratory syncytial virus-B: a multicentre observational study in FranceSlim Fourati, Alawiya Reslan, Jérôme Bourret, et al.
The Journal of Experimental Medicine|November 7, 2022
Human type I IFN deficiency does not impair B cell response to SARS-CoV-2 mRNA vaccinationAurélien Sokal, Paul Bastard, Pascal Chappert, et al.
Cell Reports. Medicine|June 16, 2023
Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patientsJoann Diray-Arce, Slim Fourati, Naresh Doni Jayavelu, et al.
The Journal of Allergy and Clinical Immunology. Global|July 25, 2025
Type 2 immune responses are associated with less severe COVID-19 in a hospitalized cohortNaresh Doni Jayavelu, Jingjing Qi, Carly E Milliren, et al.
Nature Medicine|October 7, 2016
Corrigendum: Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisitionMonica Vaccari, Shari N Gordon, Slim Fourati, et al.
Biorxiv : the Preprint Server for Biology|September 16, 2024
Putting computational models of immunity to the test - an invited challenge to predict <i>B. pertussis</i> vaccination outcomesPramod Shinde, Lisa Willemsen, Michael Anderson, et al.
Pageof 19

Showing results (171-180 of 185) with videos related to

Sort By:
Pageof 19
The Journal of Clinical Investigation|May 1, 2024
Integrated longitudinal multiomics study identifies immune programs associated with acute COVID-19 severity and mortalityJeremy P Gygi, Cole Maguire, Ravi K Patel, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 30, 2021
Performance of 30 commercial SARS-CoV-2 serology assays in testing symptomatic COVID-19 patientsChristelle Vauloup-Fellous, Sarah Maylin, Claire Périllaud-Dubois, et al.
Annals of Intensive Care|April 24, 2024
COVID-19 associated pulmonary aspergillosis in critically-ill patients: a prospective multicenter study in the era of Delta and Omicron variantsPierre Bay, Etienne Audureau, Sébastien Préau, et al.
Biorxiv : the Preprint Server for Biology|November 21, 2023
Integrated longitudinal multi-omics study identifies immune programs associated with COVID-19 severity and mortality in 1152 hospitalized participantsJeremy P Gygi, Cole Maguire, Ravi K Patel, et al.
The Lancet. Microbe|June 2, 2026
Real-world emergence of nirsevimab resistance in breakthrough infections with respiratory syncytial virus-B: a multicentre observational study in FranceSlim Fourati, Alawiya Reslan, Jérôme Bourret, et al.
The Journal of Experimental Medicine|November 7, 2022
Human type I IFN deficiency does not impair B cell response to SARS-CoV-2 mRNA vaccinationAurélien Sokal, Paul Bastard, Pascal Chappert, et al.
Cell Reports. Medicine|June 16, 2023
Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patientsJoann Diray-Arce, Slim Fourati, Naresh Doni Jayavelu, et al.
The Journal of Allergy and Clinical Immunology. Global|July 25, 2025
Type 2 immune responses are associated with less severe COVID-19 in a hospitalized cohortNaresh Doni Jayavelu, Jingjing Qi, Carly E Milliren, et al.
Nature Medicine|October 7, 2016
Corrigendum: Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisitionMonica Vaccari, Shari N Gordon, Slim Fourati, et al.
Biorxiv : the Preprint Server for Biology|September 16, 2024
Putting computational models of immunity to the test - an invited challenge to predict <i>B. pertussis</i> vaccination outcomesPramod Shinde, Lisa Willemsen, Michael Anderson, et al.
Pageof 19